Raymond James & Associates’s Community Health Systems, Inc. Series A Contingent Value Rights CYHHZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-42,246
Closed -$1K 3779
2018
Q4
$1K Sell
42,246
-472
-1% -$1 ﹤0.01% 3534
2018
Q3
$1K Sell
42,718
-645
-1% -$15 ﹤0.01% 3635
2018
Q2
$1K Buy
43,363
+6,436
+17% +$60 ﹤0.01% 3581
2018
Q1
$1K Hold
36,927
﹤0.01% 3461
2017
Q4
$1K Buy
36,927
+130
+0.4% +$1 ﹤0.01% 3419
2017
Q3
$1K Buy
36,797
+372
+1% +$5 ﹤0.01% 3396
2017
Q2
$1K Hold
36,425
﹤0.01% 3334
2017
Q1
$1K Buy
36,425
+545
+2% +$4 ﹤0.01% 3287
2016
Q4
$1K Hold
35,880
﹤0.01% 3235
2016
Q3
$1K Hold
35,880
﹤0.01% 3210
2016
Q2
$1K Sell
35,880
-225
-0.6% -$1 ﹤0.01% 3010
2016
Q1
$1K Buy
+36,105
New +$260 ﹤0.01% 2926

Other funds holding CYHHZ

Raymond James & Associates's CYHHZ Position: Q1 2019 in Review

Raymond James & Associates sold out of Community Health Systems, Inc. Series A Contingent Value Rights (CYHHZ) in Q1 2019, closing a stake of 42,246 shares — an estimated $1K sold.

Raymond James & Associates first reported a position in CYHHZ in Q1 2016 and held it in 12 quarters. The position peaked at $1K in Q4 2018. 1 fund tracked by Wall St. Rank holds CYHHZ as of Q1 2019.

  • Raymond James & Associates reported no remaining Community Health Systems, Inc. Series A Contingent Value Rights position as of Q1 2019 after selling out during the quarter.
  • Raymond James & Associates sold 42,246 Community Health Systems, Inc. Series A Contingent Value Rights shares in Q1 2019, an estimated $1K.
  • Raymond James & Associates first reported a position in Community Health Systems, Inc. Series A Contingent Value Rights in Q1 2016 and held it in 12 quarters.
  • Raymond James & Associates's Community Health Systems, Inc. Series A Contingent Value Rights position peaked at $1K in Q4 2018.
  • 1 fund tracked by Wall St. Rank held Community Health Systems, Inc. Series A Contingent Value Rights as of Q1 2019.

Based on Raymond James & Associates's 13F filing for Q1 2019, filed 6 May 2019.